An AI tool used by Spain's public health system misses 1 in 3 melanomas and was trained almost entirely on white patients. "Without rigorous validation on diver
An artificial intelligence tool employed by Spain's public health system has demonstrated a significant failure rate, misidentifying one in three melanomas. The AI was predominantly trained on data from white patients, leading to concerns about its efficacy and fairness across diverse populations. Experts warn that without comprehensive validation on varied demographics, such tools could disproportionately harm marginalized groups and compromise patient safety. AI
IMPACT AI tools in healthcare require rigorous validation on diverse populations to prevent harm and ensure equitable outcomes.